Agenda Released for ADMET 2016: Linking ADME and PK with Safety to an Overall Assessment of Risk and Benefit

London, United Kingdom, February 11, 2016 --(PR.com)-- ADME and toxicology testing are one of the most important research activities related to new drug discovery. Ensuring a good ADMET study will accelerate approval and therefore commercialisation of your drug product – and hence pharmacokinetics remain at the forefront of drug formulation and development.

Since the pharmaceutical and biotechnology companies are utilising innovative technologies, ADME and toxicology screening at the early stages of drug discovery and development has become even more imperative.

This event will explore novel and emerging non-clinical ADME approaches, structure based prediction of ADME properties, PK/PD modelling to validate drug targets, toxicity and much more.

For further information or to register please visit the event website www.admet-event.com/prcom or contact Matthew Apps on +44 (0) 207 827 6093 or mapps@smi-online.co.uk

2016 SPEAKER LINE UP:
• Nick Plant, Reader in Systems Biology, University of Surrey (CHAIRMAN)
• Thierry Lave, Head DMPK Discovery and Development Project Leaders (CNS/CVM), Roche
• Friedemann Schmidt, R&D DSAR Preclinical Safety, Sanofi-Aventis
• Kunal Taskar, Senior Investigator, DMPK, GSK
• Karelle Menochet, Principal Scientist DMPK, UCB Pharma
• Laurent Salphati, Senior Scientist, Genentech
• Carl Petersson, DMPK NCE Senior Designer, Merck Serono
• Lena Gustavsson, Head of Sections Drug-Drug Interactions, Lundbeck

To download the full agenda please visit the event website www.admet-event.com/prcom

Benefits Of Attending:
• Discover application of PBPK to drug development in rare diseases
• Review the role of drug transporters in drug delivery to CNS diseases
• Learn about better models for understanding, predicting and avoiding drug induced liver injury
• Discuss in silico approaches to evidence-based mechanistic modelling
• Analyse early dose predictions – a valuable tool in risk assessment and optimisation of small molecules

Running alongside the conference is a half-day post-conference workshop. The workshop entitled ‘Molecular properties and intermolecular interactions in virtual ADMET assessment’ will be led by Mire Zloh, Head of Medicinal and Analytical Chemistry Research Group, University of Hertfordshire and Teresa Barata, Research Associate, UCL School of Pharmacy

To register or for further information on the workshop/leaders please visit the event website www.admet-event.com/prcom

For those interested in attending, there is currently an early bird offer available saving £400 off of the conference price which expires on the 29th of February.

ADMET 2016 is sponsored by Corning and Sekisui XenoTech.

For sponsorship enquiries, contact Alia Malick on +44 (0) 207 827 6168 or amalick@smi-online.co.uk

For delegate enquiries, contact Matthew Apps on +44 (0) 207 827 6093 or mapps@smi-online.co.uk

For media enquiries, contact Zoe Gale on +44 (0) 207 827 6132 or zgale@smi-online.co.uk

11th annual ADMET conference and exhibition
13-14 June 2016
London, UK
www.admet-event.com/prcom
Contact e-mail: zgale@smi-online.co.uk
Contact tel: +44 (0) 207 827 6093
#smiADMET

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk